About Protein Forest
Protein Forest is a Healthcare company based in Lexington (United States) founded in 2002, and was acquired by ProteinSimple in December 2009. Protein fractionation instruments and software for mass spectrometry are developed. Protein Forest has raised $24.01 million across 4 funding rounds from investors including ProteinSimple, SR One and Boston Capital Ventures. Protein Forest offers products and services including dPC™ Product Platform and ProteomeChip Technology. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is Protein Forest, Inc. Its competitors include Helix, Cyrus Biotechnology and Benchling; 3 of its 3 listed competitors have raised funding.
Company details
Protein Forest develops, manufactures and markets instruments, consumables, and software products to scientists for protein separation and bioanalysis applications. The company offers digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing for mass spec analysis and western blotting. Its solutions include dPC fractionator, which runs separate samples under controlled temperature, voltage, and mixing; dPC fractionator workflow, which integrates existing mass spectroscopy workflows; dPC PlugHarvestor, which allows users to select and group a set of pH gel plugs into a tube or a microplate; and bioinformatics software products. The company serves scientists in life science, drug discovery, pharmaceutical, biotech, and diagnostic industries.
- Headquarters Lexington, United States
- Stage Acquired
- SectorsHealthcare
- Website proteinforest.com
- Social LinkedIn
- Acquired by ProteinSimple (Dec 2009)
- Legal Name Protein Forest, Inc
- Total Equity Funding$24.01M (USD)
in 4 rounds
- Latest Funding Round$750K (USD), Series B
Nov 2009
- InvestorsProteinSimple
& 4 more
- Acquired byProteinSimple
(Dec 2009)
Products & Services of Protein Forest
Protein Forest offers a comprehensive portfolio of products and services, including dPC™ Product Platform and ProteomeChip Technology.
Enables rapid separation of complex protein mixtures for analysis.
Facilitates faster protein isolation based on electrophoresis principles.
Funding Insights of Protein Forest
Protein Forest has successfully raised a total of $24.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $750 thousand completed in November 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $24.01M
- Total Rounds 4
- Last Round Series B — $750,000
- First Round $19M
(Nov 2003)
- Investors Count 4
All 4 funding rounds of Protein Forest with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2009 | $750,000 | Series B | – | – | – |
| Jul 2009 | $1.25M | Series B | – | – | – |
| Apr 2009 | $3.01M | Series B | – | – | – |
| Nov 2003 | $19M | Series A | – | SR One |
5 investors in total: 5 institutional.
Investors in Protein Forest
Protein Forest has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include ProteinSimple, SR One and Boston Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A biotechnology venture capital firm investing in innovative science. | srone.com | |||
Early-stage investments are directed toward companies in multiple sectors. | bcv.com | Boston, United States | ||
Early-stage tech startups are funded by Flybridge Capital Partners. | flybridge.com | New York, United States | ||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Provider tools to help researchers with protein analysis | 2004 | proteinsimple.com | San Jose, United States |
Investor details for Protein Forest
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Protein Forest
4 dated milestones of Protein Forest across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Protein Forest is founded.
- Funding First funding round of $19.0M.
- Funding Latest funding round, Series B, of $750K.
- Exit Acquired by ProteinSimple.
Competitors of Protein Forest
Protein Forest has 3 listed competitors in our database, 3 of them funded. They include Helix, Cyrus Biotechnology and Benchling.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| cyrusbio.com | 2014 | Seattle, United States | $31.99M | 23 | Cloud-based protein-modeling software is developed for drug discovery. | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. |
Detailed competitors of Protein Forest
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Protein Forest
The website of Protein Forest (proteinforest.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 72.9% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Protein Forest (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Protein Forest
Protein Forest was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Protein Forest is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Protein Forest is a funded company, having raised a total of $24.01M across 4 funding rounds to date. The company's 1st funding round was a Series A of $19M, raised on Nov 2003.
Protein Forest develops, manufactures and markets instruments, consumables, and software products to scientists for protein separation and bioanalysis applications. The company offers digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing for mass spec analysis and western blotting. Its solutions include dPC fractionator, which runs separate samples under controlled temperature, voltage, and mixing; dPC fractionator workflow, which integrates existing mass spectroscopy workflows; dPC PlugHarvestor, which allows users to select and group a set of pH gel plugs into a tube or a microplate; and bioinformatics software products. The company serves scientists in life science, drug discovery, pharmaceutical, biotech, and diagnostic industries.
Protein Forest's top competitors include Helix, Cyrus Biotechnology and Benchling.
Protein Forest offers dPC™ Product Platform and ProteomeChip Technology.
Protein Forest has 5 investors. Key investors include ProteinSimple, SR One, Boston Capital Ventures, Flybridge Capital Partners, and Novo Holdings.
Protein Forest operates through Protein Forest, Inc.
Yes. Protein Forest was acquired by ProteinSimple in December 2009.